Table 1. Summary of baseline characteristics (n = 60).
Variable | Category or unit | PCa (n = 27) Descriptive statistics* | Non-PCa (n = 33) Descriptive statistics* | p value† |
Age | Year | 69.67±10.29 | 62.76±7.15 | 0.003 |
Ln(serum PSA) | ng/mL | 1.73±0.87 | 1.42±0.65 | 0.121 |
Gleason score | 6 = 3+3 | 15 (71.4%) | ||
7 = 3+4 | 4 (19.0%) | |||
7 = 4+3 | 2 (9.5%) | |||
Treatment | Watchful waiting | 14 (51.9%) | ||
Prostatectomy | 13 (48.1%) | |||
Rising PSA | No | 23 (85.2%) | ||
Yes | 4 (14.8%)# | |||
Other cancer | No | 25 (92.6%) | ||
Yes | 2 (7.4%) | |||
Recurrence | No | 13 (85%) | ||
Yes | 2 (15%) |
*Numerical variables are summarized using mean ± standard deviation (SD). Categorical variables are summarized using frequency (in %).
p values are calculated from t-tests.
#Serum PSA significantly rose during follow-up.